Recent Release | 13 Jul 2020
Trade and transport margins in pharmaceuticals and other R&D-intensive industries
Spending for prescription and over-the-counter pharmaceutical products totaled $413 billion in 2012 according to the Bureau of Economic Analysis’ (BEA) trade and transports margin data. Just over half of this spending (52%) accrued to the pharmaceutical companies that produced the medicines, while the remainder was divided between transport and wholesale margins (21%) and retail margins (26%).
Compared to other research and development (R&D)-intensive manufacturing industries with significant consumer sales, the pharmaceutical and medicines manufacturing industry ranks second in terms of R&D intensity behind communications equipment, and receives the second lowest producers’ share of total spending after other miscellaneous manufacturing. Thus, the pharmaceutical industry is unique among manufacturing industries in that it devotes a large share of its revenue to R&D, despite receiving a considerably smaller share of total spending.
Tags:
You may be interested in
Post
Oxford Economics enhances its real estate solutions with the addition of MSCI data
Oxford Economics is delighted to announce a significant product enhancement to its Real Estate Economics Service and Global Economic Model, with the addition of MSCI historic real estate index data.
Find Out More
Post
From Floppy Disks to AI: A Fireside Chat with Adrian Cooper, CEO of Oxford Economics
Discover the journey of Adrian Cooper, CEO of Oxford Economics, in shaping the firm into a global leader, along with his insights and vision for the future in an exclusive interview.
Find Out More
Post
Oxford Economics introduces new Global Tech Spend Forecasts
Oxford Economics is excited to announce the launch of the Global Tech Spend Forecasts service, offering the most reliable forecasts on enterprise IT spending across 35 industries and 25 countries, with forecasts out to 2050.
Find Out More